Think of Fiasp as Faster-Acting NovoLog

Fiasp (FEE-asp, insulin aspart) will be a new "ultrafast-acting" mealtime insulin for adults with diabetes.

Think of Fiasp as similar to NovoLog. They're both insulin aspart...but Fiasp has an additive to speed absorption.

Use its brand name as a reminder of what Fiasp is..."faster-acting insulin aspart."

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals